Sort
11,323 grants matching “glioblastoma”
Illuminating the structure and function of CACNG5 and 7
$158,500Terunaga Nakagawa · Vanderbilt University · R03 · FY2022 · TR
Neurobehavioral Core
$158,472Charles Limoli · University Of California-Irvine · P01 · FY2022 · CA
Sex Differences in GBM and Head and Neck Cancers
$158,461Stanton L Gerson · Case Western Reserve University · P30 · FY2019 · CA
Clinical Studies to Circumvent Drug Resistance
$158,452Susan Bates · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
A Translational Framework for Methodological Rigor to Improve Patient Centered Ou
$158,282Francesca Dominici · Harvard School Of Public Health · K18 · FY2013 · HS
Targeting ATRX-Deficient Pediatric GBM
$158,263Carl J Koschmann · University Of Michigan At Ann Arbor · K08 · FY2021 · NS
Harnessing the Immunologic Capacity of RNA-nanoparticle Vaccines Targeting Glioblastoma
$158,188Elias Sayour · University Of Florida · K08 · FY2020 · CA
Harnessing the Immunologic Capacity of RNA-nanoparticle Vaccines Targeting Glioblastoma
$158,188Elias Sayour · University Of Florida · K08 · FY2018 · CA
Harnessing the Immunologic Capacity of RNA-nanoparticle Vaccines Targeting Glioblastoma
$158,188Elias Sayour · University Of Florida · K08 · FY2019 · CA
Harnessing the Immunologic Capacity of RNA-nanoparticle Vaccines Targeting Glioblastoma
$158,188Elias Sayour · University Of Florida · K08 · FY2017 · CA
Harnessing the Immunologic Capacity of RNA-nanoparticle Vaccines Targeting Glioblastoma
$158,188Elias Sayour · University Of Florida · K08 · FY2016 · CA
Novel DNA damage response inhibitor and alkylator combinations for GBM
$158,033Ranjit Bindra · Mayo Clinic Rochester · U19 · FY2025 · CA
MR Imaging of IDH Mutational Status in Brain Tumors
$157,938Sabrina Miriam Ronen · University Of California, San Francisco · R21 · FY2013 · CA
PFK-015: An inhibitor of PFKFB3 to treat Glioblastomas
$157,920Gilles Hugues Tapolsky · Advanced Cancer Therapeutics, Llc · R43 · FY2012 · CA
Thermally Targeted Delivery of c-Myc Inhibitory Polypeptides to Malignant Gliomas
$157,704Drazen Raucher · University Of Mississippi Med Ctr · R21 · FY2011 · CA
MOLECULAR GUIDED SURGERY FOR IMPROVED RESECTION OF GLIOBLASTOMA MULTIFORME
$157,680Jonathan T Elliott · Dartmouth College · K99 · FY2017 · CA
MOLECULAR GUIDED SURGERY FOR IMPROVED RESECTION OF GLIOBLASTOMA MULTIFORME
$157,680Jonathan T Elliott · Dartmouth College · K99 · FY2016 · CA
Microfluidic Device for Isolating Rare Blood Cells
$157,500Lance L Munn · Massachusetts General Hospital · R21 · FY2008 · CA
Cell invasion, motility, and proliferation level estimate maps in gliomas
$157,427Benjamin M. Ellingson · University Of California Los Angeles · R21 · FY2013 · CA
Pre-Clinical Vector Production Core
$157,020William F. Goins · Brigham And Women'S Hospital · P01 · FY2022 · CA
Curated copy number variation TCGA database and analytical platform for use in ca
$156,809Soheil C Shams · Biodiscovery, Inc. · R43 · FY2014 · CA
The role of microglia and macrophages in the development of brain tumors
$156,552Joanna Phillips · University Of California, San Francisco · K08 · FY2012 · NS
Development of novel thiobarbituric acid analogs for malignant brain tumors
$156,405Sang Yong Lee · Pennsylvania State Univ Hershey Med Ctr · R21 · FY2013 · CA
Core 2: Neuro-Imaging Core
$156,349Benjamin M. Ellingson · University Of California Los Angeles · P50 · FY2020 · CA
Targeting glioblastoma stem-like cells with custom-designed viral vectors
$156,335Darin J Falk · Lacerta Therapeutics, Inc. · R42 · FY2019 · CA